Samantha Clark, MHS
- Research Associate
- Division: Health Systems
Center & Institute Affiliations
MHS, Johns Hopkins Bloomberg School of Public Health, 2013
Master of Health Science in Health Economics with an interest in gaining additional research experience in economic modeling and evaluation, specifically in examining the impact of health intervention scale-up in resource-constrained settings.
Honors and Awards
St. Mary’s Departmental Award in Economics, 2008
Most recent publications
- Melo M, Clark S, Barrio D. Miniaturization and globalization of clinical laboratory activities. Clin Chem Lab Med. April 2011; 49(4):581-6.
- Constenla D and Clark S. Financing dengue vaccine introduction in the Americas: challenges and opportunities. Expert Rev Vaccines. January 2016; 22(1)-13.
- Ozawa S, Clark S, Portnoy A, Grewal S, Brenzel L, and Walker D. Return on investment from childhood immunization in Low- And Middle-Income Countries, 2011–20. Health Affairs. February 2016; 35(2):199-207
- Verma R, Clark S, Leider J, and Bishai D. Impact of state public health spending on incidence of mumps, pertussis, and rubella in the United States from 1980-2009. Health Services Research. March 2016. Advance online publication. Doi: 10.1111/1475-6773.12480
- Haidari L, Brown S, Constenla D, Zenkov E, Ferguson M2 de Broucker G, Ozawa S, Clark S, Lee BY. The economic value of increasing geospatial access to tetanus toxoid immunization in Mozambique. Vaccine. July 2016; 29(35):4161-5.
- Decade of Vaccine Economics (DOVE) Phase IV
- Demonstrating the incremental and societal impact of reaching hard-to-reach populations through routine immunization
- Modeling the Economic Burden of Adult Vaccine Preventable Diseases (VPDs) in the United States
- Return on investment analyses for mental health